Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 85.87M | 84.32M | 82.57M | 78.10M | 81.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.87M | 84.32M | 82.57M | 78.10M | 81.76M |
| Cost of Revenue | 20.45M | 19.42M | 19.86M | 20.23M | 19.64M |
| Gross Profit | 65.42M | 64.90M | 62.71M | 57.88M | 62.13M |
| SG&A Expenses | 38.83M | 35.56M | 36.75M | 37.49M | 39.29M |
| Depreciation & Amortization | 1.44M | 2.51M | 2.51M | 2.51M | 2.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.69M | 72.43M | 76.84M | 83.61M | 90.43M |
| Operating Income | 8.17M | 11.89M | 5.73M | -5.50M | -8.66M |
| Income Before Tax | -6.30M | -2.10M | -6.57M | -17.56M | -23.54M |
| Income Tax Expenses | 2.01M | 1.06M | 427.00K | 435.00K | 421.00K |
| Earnings from Continuing Operations | -8.31 | -3.16 | -7.00 | -18.00 | -23.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.31M | -3.16M | -7.00M | -18.00M | -23.96M |
| EBIT | 8.17M | 11.89M | 5.73M | -5.50M | -8.66M |
| EBITDA | 10.60M | 14.40M | 8.62M | -2.94M | -5.70M |
| EPS Basic | -0.17 | -0.09 | -0.19 | -0.62 | -0.96 |
| Normalized Basic EPS | -0.01 | 0.01 | -0.05 | -0.32 | -0.47 |
| EPS Diluted | -0.17 | -0.10 | -0.19 | -0.62 | -0.96 |
| Normalized Diluted EPS | -0.01 | 0.01 | -0.05 | -0.32 | -0.47 |
| Average Basic Shares Outstanding | 197.45M | 180.81M | 155.65M | 130.49M | 105.33M |
| Average Diluted Shares Outstanding | 197.47M | 180.83M | 155.66M | 130.49M | 105.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
